ArticleBMC gastroenterology2025

Ustekinumab trough concentrations predict clinical remission in perianal fistulizing crohn's disease: a real-world retrospective cohort study.

Xiaoyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.